Does Semaglutide Affect Testosterone? What Men Should Expect

Executive Summary

The question does semaglutide affect testosterone keeps coming up because millions of men are now using GLP-1 receptor agonists like Ozempic and Wegovy, and many of them are also dealing with low-T symptoms. The short answer is: yes, semaglutide can shift testosterone — but usually not in the direction most men fear.

In overweight or obese men, the dominant signal from the research is that GLP-1-driven weight loss tends to improve bioavailable testosterone. Adipose tissue converts testosterone to estrogen through aromatization, so when body fat falls, that conversion rate drops and available testosterone rises. A 2025 study presented at the Endocrine Society found meaningful testosterone improvement in men with obesity after roughly 18 months on a GLP-1 receptor agonist. However, a 2024 claims-based analysis found an association between semaglutide use and increased risk of testosterone deficiency and erectile dysfunction in non-diabetic males — a finding that is still being debated but is worth taking seriously.

The nuance is that rapid calorie restriction itself — regardless of the drug causing it — can temporarily suppress the hypothalamic-pituitary-gonadal axis. If semaglutide tanks appetite so aggressively that food intake collapses and protein intake craters, that alone can lower testosterone and energy. The drug is not directly androgenic or anti-androgenic; the outcomes depend heavily on starting body composition, diet quality during treatment, and how carefully labs are monitored. Use this guide alongside GLP-1 + TRT, low testosterone symptoms, and compare providers to understand what monitoring your specific situation actually requires.

At-a-Glance Comparison

Semaglutide's effect on testosterone is not a fixed outcome — it depends on baseline weight, diet quality, and how aggressively calories fall. Most obese men see improvement. Lean men or those with very aggressive deficits should watch their labs closely.

How Semaglutide Can Change Testosterone Levels

Semaglutide does not interact directly with testosterone receptors or suppress testosterone production at the pituitary level the way exogenous androgens do. Its effect on testosterone is mostly indirect — and understanding the mechanism explains why results vary widely between men. Buyers searching for does semaglutide affect testosterone usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The primary pathway runs through body weight and fat distribution. Adipose tissue contains the enzyme aromatase, which converts testosterone into estrogen. Obese men tend to have higher aromatase activity, which reduces bioavailable testosterone and elevates estrogen. When semaglutide drives significant fat loss — which it does reliably in most users — that conversion rate falls, and circulating testosterone tends to rise. This is sometimes called 'weight-loss-mediated testosterone recovery,' and it is the mechanism behind why bariatric surgery often normalizes testosterone in obese men without TRT. Semaglutide appears to produce a similar but smaller signal. There is also an insulin sensitivity pathway: better glycemic control and lower insulin resistance are associated with improved SHBG regulation, which affects how much free testosterone is available. Some research suggests GLP-1 receptor agonists may have direct effects on testicular Leydig cells, though the evidence here is preliminary. The practical takeaway is that in overweight and obese men, the net effect of semaglutide on testosterone is frequently positive — but only if weight is actually being lost and lean mass is not being destroyed. Review testosterone levels by age chart and semaglutide vs tirzepatide comparison to add clinical context to your baseline numbers. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: men assume weight loss on semaglutide automatically fixes low testosterone without checking labs, missing cases where the HPG axis remains suppressed despite weight loss — or where low T was never fat-related to begin with. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Who Tends to See Testosterone Improvement on Semaglutide

The men most likely to see testosterone improve on semaglutide are those whose low-T symptoms are largely driven by excess body fat and metabolic dysfunction rather than structural or primary hypogonadism. Buyers searching for does semaglutide affect testosterone usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The clearest beneficiary profile is a man with BMI above 27–30, pre-diabetes or insulin resistance, low total or free testosterone, and symptoms like fatigue, low libido, poor recovery, and reduced motivation. In this profile, the fat is actively suppressing testosterone via aromatization and SHBG disruption. Weight loss — however it is achieved — tends to relieve those suppressive forces. A 2024 study published in Endocrine Abstracts directly comparing semaglutide to TRT in men with functional hypogonadism found that both significantly improved testosterone levels, with the semaglutide group also showing better sperm concentration outcomes. A 2025 Endocrine Society analysis confirmed meaningful testosterone gains in men with obesity after roughly 18 months on GLP-1 therapy. Men who have been obese for years and have not gotten meaningful labs since their weight peaked are often the most surprised to find that their testosterone normalizes with structured weight loss — meaning TRT might never have been necessary. Use best testosterone blood tests online to get proper baseline data before committing to any treatment plan. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: men who improve on semaglutide credit the drug itself for testosterone recovery, when the actual mechanism is the weight loss — meaning the gains are maintenance-dependent and will reverse if weight is regained. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Who Is at Risk for a Drop in Testosterone

The concerning signal — increased risk of testosterone deficiency and erectile dysfunction in non-diabetic males using semaglutide — comes from a 2024 claims-based analysis in the Journal of Sexual Medicine. It is important to understand what that finding means and, more importantly, what it does not mean. Buyers searching for does semaglutide affect testosterone usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

A claims-based study tracks prescriptions and diagnoses but cannot confirm causality, control for confounders, or separate the effect of the drug from the effect of the aggressive calorie restriction it causes. In lean or normal-weight men who use semaglutide for modest weight loss, the aromatization benefit is much smaller — there is less fat to lose, so less testosterone suppression to reverse. If semaglutide simultaneously causes severe appetite suppression, very low calorie intake, and poor protein intake, that alone can suppress the HPG axis. Extended caloric restriction is a well-documented cause of lower LH, FSH, and testosterone, especially in athletes and men who are already lean. There is also a behavioral pathway: men who are nauseated, fatigued, and eating very little in the early weeks of semaglutide titration may see both libido and testosterone-related symptoms decline even if labs do not show a significant change. The population most at risk appears to be non-obese men using semaglutide for relatively small amounts of weight loss with very aggressive deficit maintenance. If you are in that profile, close monitoring is the standard of care. Review low testosterone symptoms so you know which symptoms warrant a lab check rather than watchful waiting. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: the 2024 risk signal gets either over-interpreted (semaglutide always lowers testosterone) or dismissed entirely, when the right response is targeted monitoring for the subset of men where the risk profile is highest. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

What to Monitor: Labs, Timeline, and Warning Signs

Whether you expect testosterone to improve or are watching for a potential decline, the monitoring framework is the same: baseline, early recheck, and structured follow-up. Most of the uncertainty about semaglutide and testosterone exists because men are starting this medication without any hormone baseline. Buyers searching for does semaglutide affect testosterone usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Before starting semaglutide, a reasonable baseline panel includes total testosterone, free testosterone, SHBG, estradiol, LH, FSH, CBC, CMP, fasting glucose, A1c, and lipids. If you have symptoms suggesting low testosterone, add PSA if over 40. Get a recheck at 12 weeks if symptoms have changed or you are in a high-risk profile. Get another recheck at 6 months regardless. The timeline matters because the testosterone signal from weight loss is not immediate — meaningful aromatization reduction usually requires 3 to 6 months of sustained fat loss, and the HPG axis takes additional time to resync. Warning signs that warrant earlier labs: worsening fatigue that does not resolve after the GLP-1 adjustment period, declining libido or sexual function past week 8, loss of motivation or mood that tracks with the semaglutide start date, or any new symptoms that look like the classic low testosterone symptoms checklist. If follow-up labs confirm low testosterone that does not improve with weight loss over 6 months, the case for TRT becomes stronger. Use compare providers, best online TRT clinics compared 2026, and GLP-1 + TRT for context on combining both therapies if that eventually becomes the plan. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: men start semaglutide, feel some initial fatigue and low libido from the appetite-adjustment period, assume it is just the drug's side effect profile, and never check whether testosterone has actually shifted — missing a window to intervene early. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

If you are on semaglutide and wondering whether your testosterone needs monitoring — or if low T symptoms have appeared since starting a GLP-1 — the right move is a proper baseline panel and a provider who can read the full picture. Compare clinics on whether they include labs, follow up on results, and have clinical depth in both GLP-1 and hormone management before you commit.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

Does semaglutide lower testosterone?

Not directly. Semaglutide does not suppress testosterone production the way exogenous androgens do. In overweight and obese men, the weight loss semaglutide drives often raises bioavailable testosterone by reducing fat-tissue aromatization. However, very aggressive caloric restriction — from any cause — can temporarily suppress the HPG axis and lower testosterone. Lean men and those with very poor diet quality during treatment may be at higher risk for a transient decline.

Can semaglutide raise testosterone?

Yes, in overweight and obese men it often does. Multiple studies suggest GLP-1 receptor agonists can improve testosterone levels through weight-loss-mediated reduction in aromatase activity. A 2025 Endocrine Society study found meaningful testosterone improvement in men with obesity after 18 months on a GLP-1 receptor agonist. The benefit is strongest in men with significant excess body fat and metabolic dysfunction, not in lean men using the drug for modest weight loss.

Should I check my testosterone before starting semaglutide?

Yes, especially if you already have low-T symptoms or are not significantly overweight. Baseline labs — total T, free T, SHBG, estradiol, LH, FSH — give you a reference point so you can tell whether semaglutide is helping, hurting, or having no effect on your hormones. Starting without a baseline makes it nearly impossible to interpret symptoms that arise during treatment.

Why did my libido drop after starting Ozempic?

Several things can cause this in the first 8 to 12 weeks of semaglutide use: nausea and general GI discomfort, severe appetite suppression reducing protein and caloric intake, early caloric-restriction-induced HPG suppression, fatigue from metabolic adjustment, and anxiety about side effects. If libido does not recover after the titration period or worsens further after the acute adjustment phase, get labs and rule out a meaningful testosterone drop before assuming it is just the drug.

Do I need TRT if I am already on semaglutide?

Not necessarily. For obese men with low testosterone that is largely driven by body fat, semaglutide-driven weight loss may improve testosterone enough to resolve symptoms without TRT. The decision depends on whether low T is structural or functional, how severe symptoms are, whether labs normalize after meaningful weight loss, and how long that improvement takes. If testosterone remains low after 6 months of meaningful fat loss, TRT may become more clearly justified.

Is the risk of low testosterone from semaglutide serious?

There is a real but context-dependent signal. A 2024 claims-based analysis found an elevated risk of hypogonadism and erectile dysfunction in non-diabetic men using semaglutide. That finding does not mean semaglutide causes low T in all men — it means a specific profile of men (likely lean, aggressive deficit, low protein intake) may be at elevated risk. The right response is baseline labs, adequate protein, and a follow-up recheck at 3 and 6 months — not avoiding semaglutide entirely.